Loading...

Embecta Corp.

EMBCV•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$33.33
$-3.43(-9.33%)

Embecta Corp. (EMBCV) Stock Overview

Explore Embecta Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.8/100

Key Financials

Market Cap1.9B
P/E Ratio13.05
EPS (TTM)N/A
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

EMBCV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Embecta Corp. (EMBCV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.05 and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;